Lobe Sciences Ltd.
LOBEF · OTC
8/31/2024 | 8/31/2023 | 8/31/2022 | 8/31/2021 | |
|---|---|---|---|---|
| Revenue | $136 | $841 | $0 | $0 |
| % Growth | -83.8% | – | – | – |
| Cost of Goods Sold | $2 | $24 | $0 | $0 |
| Gross Profit | $134 | $817 | -$10 | $0 |
| % Margin | 98.7% | 97.1% | – | – |
| R&D Expenses | $386 | $1,248 | $418 | $1,372 |
| G&A Expenses | $1,769 | $2,596 | $3,447 | $3,299 |
| SG&A Expenses | $1,780 | $2,885 | $3,695 | $5,003 |
| Sales & Mktg Exp. | $10 | $289 | $248 | $1,704 |
| Other Operating Expenses | $85 | -$1 | $10 | $0 |
| Operating Expenses | $2,251 | $4,132 | $4,123 | $6,375 |
| Operating Income | -$2,116 | -$3,359 | -$4,113 | -$6,375 |
| % Margin | -1,553.5% | -399.6% | – | – |
| Other Income/Exp. Net | -$2,272 | -$1,143 | -$8,140 | -$17,469 |
| Pre-Tax Income | -$4,388 | -$4,502 | -$12,253 | -$23,844 |
| Tax Expense | $33 | $205 | $0 | -$1,024 |
| Net Income | -$4,421 | -$4,707 | -$12,253 | -$9,658 |
| % Margin | -3,245.8% | -560% | – | – |
| EPS | -0.036 | -0.045 | -0.32 | -0.3 |
| % Growth | 19.7% | 85.9% | -6.7% | – |
| EPS Diluted | -0.036 | -0.045 | -0.32 | -0.3 |
| Weighted Avg Shares Out | 122,136 | 104,351 | 37,862 | 32,494 |
| Weighted Avg Shares Out Dil | 122,134 | 104,351 | 37,862 | 32,494 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $187 | $39 | $0 | $0 |
| Depreciation & Amortization | $85 | $44 | $10 | $216 |
| EBITDA | -$4,116 | -$4,420 | -$4,113 | -$6,159 |
| % Margin | -3,021.9% | -525.9% | – | – |